Premier Biomedical Inc (BIEI)

[txhighopes]

Insider Financial Conclusion:

In this article, we assessed the last news released by the company, which did not have a market reaction, but have some value for market participants. First, the company’s products were tried out by a fibromyalgia sufferer, who talked very positively about the experience. Furthermore, the company released its first quarterly report for 2017, and its 2016 annual report. We did not see any significant change on the books. Finally, we are glad that the company retired its stock warrants’ offering, as it would have increased the risk of dilution. Like before, try to follow the company closely, as it may release good news very soon that may really affect the share price.